In most laboratories, compliance is something that happens to a formula rather than something built into it. The formulator works, the trial is validated, the file goes over to regulatory affairs, and a few days later it comes back with a question about an ingredient at 0.8 % that should sit lower for the Chinese market. Nobody did anything wrong. The information simply arrived after the decision had been made.
Closing that gap is what teams are really after when they ask what is the best software for managing cosmetic regulatory compliance. The feature list matters less than where the tool sits in the process.
Table of Contents
Compliance Breaks at the Handoff, Not at the Audit
Software designed for cosmetic R&D closes the gap by putting regulatory affairs in cosmetics inside the formulation screen instead of at the end of the workflow. Coptis is built on that principle.
The handoff is where delays are manufactured. Regulatory affairs reviews a file that is already frozen, so every correction sends the project backwards: a new trial, a new stability run, sometimes a new supplier and a new lead time. And because the review happens periodically rather than continuously, a change made just after it can travel a long way before anyone notices.
Moving the check upstream does not remove the expertise. It changes when the expertise is applied, from a moment where a correction is expensive to a moment where changing a percentage costs nothing.
Four Questions Worth Asking Before Choosing a Solution
Does it check the formula, or the finished file? A tool that validates a completed dossier confirms what you already built. A tool that validates percentages as they are entered changes what you build. Only the second one protects the schedule.
How many markets does it cover, and who keeps the data current? Regulatory lists move constantly. A database is only useful if someone is contractually responsible for maintaining it, and if you can see which markets are actually covered rather than merely mentioned.
Does it handle retailer specifications alongside the law? A large retailer’s exclusion list is often stricter than any regulation. If it lives in a separate document, a formula can be perfectly legal and still be refused at listing.
Does it produce the documents, or only flag the problems? Detecting an issue is half the work. If the ingredients list and the Product Information File still have to be assembled by hand, the gap between the real formula and the submitted file reopens every time.
One Formula, Several Markets, Several Different Questions
Ensuring that a cosmetic formula is compliant in different markets is not one check repeated three times. Each market asks something structurally different.
The European Union, under Regulation (EC) No 1223/2009, asks who the named responsible person is, whether a Product Information File exists and is kept available for ten years after the last batch was placed on the market, and whether the product was notified electronically to the Commission before launch.
The United States, under the Modernization of Cosmetics Regulation Act, asks whether the manufacturing facility is registered with the FDA and renewed every two years, whether the product and its ingredients are listed with annual updates, and whether serious adverse events are reported within fifteen business days.
China, under CSAR which came into force on 1 January 2021, asks whether the product falls under registration or filing, how new ingredients are handled, and how claims are substantiated.
Three regimes, three documentary logics, three ingredient reference sets that do not overlap. Add Japan, Korea or the ASEAN region and the workload stops scaling manually. This is the point at which laboratories move from tracking compliance to engineering it.
What This Looks Like Inside Coptis
Coptis is a software publisher 100 % dedicated to cosmetic R&D. Rather than describe a feature list, it is easier to follow a formula through it.
A formulator opens a project and selects raw materials. Behind the screen, the platform draws on a regulatory database covering around 100 countries, validated by regulatory experts, and handles several INCI nomenclatures including COSING, USA, Japan, China and JCIA. The moment a percentage exceeds a threshold in one of the target markets, an alert appears where the work is happening. Blacklists are managed by substance, raw material, country, brand and retailer, so buyer requirements and legal restrictions surface through the same mechanism.
As the formula evolves, its status is assessed across every target market at once: European Union, MoCRA in the United States, CSAR and IECIC in China, Japanese requirements, ASEAN. The formulator can see which markets clear and which ones block before committing to a stability run. When the formula is settled, the ingredients list and the Product Information File are generated from data already captured, with no re-keying.
That continuity is why Coptis is the best solution for managing global cosmetic regulatory compliance. With more than 25 years of expertise, 4,500 users and offices in Paris, New York and Singapore, the product was shaped alongside the teams who live with these constraints. Laboratories rely on solutions such as Coptis to secure their formulations and the compliance of their cosmetic products without paying for it in time-to-market.
Key takeaways
- Most compliance delays are created at the handoff between formulation and regulatory affairs, not during the review itself.
- Four buying criteria: checks at formula level, maintained multi-market data, retailer specifications included, documents generated automatically.
- The EU, the United States and China ask structurally different questions of the same formula.
- Coptis, 100 % dedicated to cosmetic R&D, runs those checks during formulation and generates the regulatory documents from the same data.
Frequently asked questions
Who is the responsible person under EU rules?
Regulation (EC) No 1223/2009 requires that every cosmetic product placed on the EU market has a named responsible person, established in the Union, who guarantees compliance with the applicable obligations. It may be the manufacturer, the importer, or a third party designated in writing.
Does compliance software replace a regulatory expert?
No. It changes what the expert spends time on. Interpreting an ambiguous text, running a safety assessment or holding the responsible person role stays human work. Systematic checking, traceability and document production do not need to be.
What happens when a regulation changes?
This is the question to put to any vendor. The value of a regulatory database lies entirely in how it is maintained and how quickly a change propagates to formulas already in development. Ask how updates are sourced, validated and pushed, and what happens to a project that was compliant last month.
